Terranueva Corporation

Equities

TEQ

CA88105H1010

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 02:40:25 2024-02-05 pm EST			5-day change	1st Jan Change
0.03 ^CAD	+50.00%		-.--%	+20.00%

2023	Terranueva Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	CI
2023	Terranueva Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	CI

Terranueva Gets an Additional $500,000 in Financial Support from Canada Economic Development

April 07, 2021 at 08:00 am EDT

Terranueva Corporation announced that Canada Economic Development has granted the Corporation a $500,000 loan to the business to support its day-to-day operations, bringing CED's support to the Corporation to $1 million to date.

Latest news about Terranueva Corporation

Terranueva Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-24	CI
Terranueva Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-29	CI
Terranueva Corporation Auditor Raises 'Going Concern' Doubt	23-05-04	CI
Terranueva Corporation Reports Earnings Results for the First Quarter Ended December 31, 2022	23-05-04	CI
Terranueva Corporation Reports Earnings Results for the Full Year Ended September 30, 2022	23-05-04	CI
Terranueva Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-03	CI
Terranueva Corporation announced that it has received CAD 2.95 million in funding	22-07-12	CI
Terranueva Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-26	CI
Terranueva Corporation Approves Appointment of PricewaterhouseCoopers LLP as Auditor	22-04-14	CI
Terranueva Corporation Approves Appointment of Marianne Fortier-Landry as Director	22-04-14	CI
Terranueva Corporation Reports Earnings Results for the First Quarter Ended December 31, 2021	22-02-18	CI
Terranueva Corporation Reports Earnings Results for the Full Year Ended September 30, 2021	22-01-28	CI
Terranueva Corporation Auditor Raises 'Going Concern' Doubt	22-01-27	CI
Terranueva Corporation Reports Earnings Results for the Third Quarter Ended June 30, 2021	21-08-06	CI
Terranueva Corporation Reports Earnings Results for the Second Quarter Ended March 31, 2021	21-05-27	CI
Terranueva Corporation Appoints Jean-Luc Landry as Chief Executive Officer	21-04-27	CI
Terranueva Corporation Announces Board and Executive Changes	21-04-27	CI
Terranueva Gets an Additional $500,000 in Financial Support from Canada Economic Development	21-04-07	CI
Terranueva Corporation announced that it has received CAD 1.05 million in funding	21-03-21	CI
Terranueva Corporation Auditor Raises 'Going Concern' Doubt	21-01-27	CI
Terranueva Corporation Reports Earnings Results for the Full Year Ended September 30, 2020	21-01-27	CI
Terranueva Corporation Announces New Organizational Structure	20-11-01	CI
Terranueva Corporation Announces New Organizational Structure	20-11-01	CI
Terranueva Corporation Obtains $500,000 in Financial Support from Economic Development Canada	20-09-24	CI
Corporation Terranueva Announces That It Has Files Licence Amendment Request with Health Canada	20-09-04	CI

Chart Terranueva Corporation

Duration

Period

More charts

Company Profile

Terranueva Corporation is a Canada-based cannabis company. The Company is focused on providing medicinal and recreational cannabis to the Canadian and international markets. It is engaged in research and development focused on the cannabis industry. The Company is also focused on implementing a modular production approach in its process automation. The Companyâs wholly owned subsidiary is Terranueva Pharma Corporation.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
TERRANUEVA CORPORATION	+20.00%	1.01M
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6.26%	11.42B

Other Biotechnology & Medical Research